Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Land: Singapore

Sprog: engelsk

Kilde: HSA (Health Sciences Authority)

Tilgængelig fra:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Klasse:

Class D medical device

Fremstillet af:

Bio-Technology General (Israel) Ltd.

Terapeutisk område:

Orthopaedics

Terapeutiske indikationer:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Produkt oversigt:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Autorisation dato:

2017-04-28